Tartaric Acid
Medchemexpress LLC DL-tartaric acid | 133-37-9 | MFCD00071626 | 98.0% | 150.09 | C4H6O6 | 25g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Medchemexpress LLC Tartaric acid (sodium hydrate) | 6131-98-2 | MFCD00150038 | 190.08 g/mol | C4H7NaO7 | 500 G
Tartaric acid sodium hydrate is the sodium salt hydrate of L-(+)-tartaric acid supplied as a white to off-white crystalline solid for laboratory and food-related applications. It is used as an endogenous metabolite reagent and described as a food additive; product documentation including SDS and COA is provided by the supplier.
Medchemexpress LLC ENMD-2076 | 934353-76-1 | 99.99% | 375.47 | 100 MG
ENMD-2076 is a multi-targeted kinase inhibitor with high selectivity towards Aurora A versus Aurora B. It inhibits HUVEC growth and shows antiproliferative effects on human leukemia cell lines. This compound induces G2-M-phase arrest and apoptosis in U937 cells and inhibits Flt3 and Kit autophosphorylation. In vivo, ENMD-2076 demonstrates dose-dependent inhibition of tumor growth and is well tolerated in animal studies.
- Multi-targeted kinase inhibitor.
- Inhibits HUVEC growth.
- Shows antiproliferative effects on leukemia cell lines.
- Induces G2-M-phase arrest and apoptosis.
- Inhibits Flt3 ligand (FL)-induced Flt3 autophosphorylation.
- Inhibits stem cell factor (SCF)-induced Kit autophosphorylation.
- Inhibits VEGFR2/KDR autophosphorylation.
- Results in dose-dependent inhibition of tumor growth in vivo.
Chem-Impex International, Inc. (-)-Dibenzoyl-L-tartaric acid | MFCD00003074 | 1KG
(-)-Dibenzoyl-L-tartaric acid, MFCD00003074, 1KG
Chem-Impex International, Inc. (+)-O,O'-Di-p-toluoyl-D-tartaric acid | 32634-68-7 | MFCD00008552 | 1KG
(+)-O,O'-Di-p-toluoyl-D-tartaric acid, 32634-68-7, MFCD00008552, 1KG
Selleck Chemical LLC Tartaric acid S2997-100mg
Tartaric acid (2 3-Dihydroxysuccinic acid) is a white crystalline organic acid isolated from many plants particularly tamarinds and grapes and is used as an antioxidant and an additive agent to give a sour taste
Sigma Aldrich Fine Chemicals Biosciences DL-Tartaric acid | 133-37-9 | MFCD00071626
DL-Tartaric acid | Purity: 99% | MW: 150.09 | 133-37-9 | MFCD00071626
Medchemexpress LLC DL-Tartaric acid | 133-37-9 | 98.0% | 150.09 | C4H6O6 | 500g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Apexbio Technology LLC ENMD-2076 934353-76-1 10mM (in 1mL DMSO)
ENMD-2076 (CAS 934353-76-1) is a selective inhibitor of Aurora A kinase (IC50 14 nM) and FLT3 (IC50 1 86 nM) with additional inhibitory activity against multiple tyrosine kinases implicated in angiogenesis and cell proliferation including RET FLT4/VEGFR3 SRC CSF1R NTRK1 FGFR1/2 VEGFR2/KDR LCK and PDGFR (IC50 1 86 120 nM) ENMD-2076 disrupts cell cycle progression by arresting cells in the G2/M phase through inhibition of Aurora kinases suppresses the PI3K/AKT signaling pathway and demonstrates cytotoxic effects in hematologic malignancy and solid tumor cell lines (in vitro IC50 25 700 nM) In vivo it reduces tumor growth and angiogenesis in xenograft models supporting its use in cancer research and antiangiogenic studies
Medchemexpress LLC DL-tartaric acid | 133-37-9 | MFCD00071626 | 98.0% | 150.09 g/mol | C4H6O6 | 1mL
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Medchemexpress LLC ENMD-2076 | 934353-76-1 | 99.99% | 375.47 | 10 MG
ENMD-2076 is a multi-targeted kinase inhibitor, demonstrating significant activity against Aurora A, Flt3, KDR/VEGFR2, and other kinases. It effectively inhibits cellular autophosphorylation and induces G2-M-phase arrest and apoptosis in various cell lines. In vivo studies show dose-dependent inhibition of tumor growth and tumor regression, with the compound being well tolerated.
- Inhibits multiple kinases including Aurora A, Flt3, VEGFR2
- Induces G2-M-phase arrest and apoptosis
- Demonstrates antiproliferative activity against human cell lines
- Inhibits cellular Flt3 ligand (FL)-induced Flt3 autophosphorylation
- Inhibits stem cell factor (SCF)-induced Kit autophosphorylation
- Inhibits VEGFR2/KDR autophosphorylation
- Leads to dose-dependent inhibition of tumor growth in vivo